2007/012 NICE publishes guidance on fludarabine for chronic lymphocytic leukaemia
As no appeals against its draft recommendations were received, the National Institute for Health and Clinical Excellence (NICE) has today published its guidance on the use of fludarabine monotherapy for the treatment of chronic lymphocytic leukaemia (CLL). The guidance does not recommend the use of fludarabine monotherapy for first line treatment of CLL.
 |
2007/012 NICE publishes guidance on fludarabine for chronic lymphocytic leukaemia 28 February 2007 (30.1Kb 10sec @ 28.8Kbps) |
